A Prospective Sub-Study of the Global Hypophosphatasia Registry
Public ClinicalTrials.gov record NCT05234567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Observational Sub-Study of the Global Hypophosphatasia Registry to Describe the Potential Risk of Immune-Mediated Loss of Pharmacological Effect of Asfotase Alfa in Participants With Hypophosphatasia
Study identification
- NCT ID
- NCT05234567
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Alexion Pharmaceuticals, Inc.
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- Asfotase Alfa Biological
Biological
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2022
- Primary completion
- Jul 17, 2028
- Completion
- Jul 17, 2028
- Last update posted
- Feb 8, 2026
2022 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Hartford | Connecticut | 06106 | Recruiting |
| Clinical Trial Site | Chicago | Illinois | 60611 | Recruiting |
| Clinical Trial Site | Boston | Massachusetts | 02122 | Recruiting |
| Clinical Trial Site | Kansas City | Missouri | 64108 | Recruiting |
| Clinical Trial Site | Mineola | New York | 11501 | Recruiting |
| Clinical Trial Site | Cincinnati | Ohio | 45229 | Not yet recruiting |
| Clinical Trial Site | Columbus | Ohio | 43203 | Recruiting |
| Clinical Trial Site | Pittsburgh | Pennsylvania | 15224 | Not yet recruiting |
| Clinical Trial Site | Nashville | Tennessee | 37112 | Recruiting |
| Clinical Trial Site | Salt Lake City | Utah | 84108 | Recruiting |
| Clinical Trial Site | Charlottesville | Virginia | 22903 | Recruiting |
| Clinical Trial Site | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05234567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05234567 live on ClinicalTrials.gov.